Medicine and Dentistry
Acute Coronary Syndrome
17%
Acute Heart Infarction
29%
All Cause Mortality
13%
Angina pectoris
10%
Angiography
21%
Angioplasty
16%
Apoplexy
13%
Artery
20%
Artery Disease
9%
Atrial Fibrillation
10%
Cardiovascular Disease
19%
Cardiovascular System
25%
Cause of Death
13%
Combination Therapy
14%
Coronary Angiography
51%
Coronary Artery
40%
Coronary Artery Bypass Graft
11%
Coronary Artery Disease
31%
COVID-19
16%
Diabetes Mellitus
10%
Disease
8%
Drug-Eluting Stent
30%
Fractional Flow Reserve
29%
Hazard Ratio
43%
Heart Disease
11%
Heart Failure
21%
Heparin
13%
Hypoxia
10%
In Vitro
10%
Infection
11%
Influenza Vaccination
12%
Ischemic Heart Disease
9%
Myocardial Infarction
79%
Observational Study
23%
Percutaneous Coronary Intervention
100%
Primary Percutaneous Coronary Intervention
25%
Randomized Clinical Trial
16%
Randomized Controlled Trial
13%
Rapamycin
10%
Restenosis
20%
Revascularization
18%
ST Segment Elevation Myocardial Infarction
60%
Stenosis
11%
Stent Thrombosis
38%
Symptom
11%
Takotsubo Cardiomyopathy
12%
Target Lesion
8%
Thrombus
9%
Thrombus Aspiration
23%
Transluminal Coronary Angioplasty
53%
Pharmacology, Toxicology and Pharmaceutical Science
6 N,n' Dimethylarginine
5%
Acute Coronary Syndrome
12%
Acute Heart Infarction
33%
All Cause Mortality
23%
Artery Disease
6%
Atrial Fibrillation
11%
Beta Adrenergic Receptor Blocking Agent
7%
Bivalirudin
23%
Bleeding
9%
Cardiovascular Disease
13%
Cardiovascular Risk
7%
Cause of Death
11%
Combination Therapy
11%
Coronary Artery Disease
29%
Disease
10%
Fibrinogen Receptor
6%
Heart Disease
10%
Heart Failure
19%
Heart Infarction
85%
Heparin
29%
Hypothermia
6%
Hypoxia
6%
Infarction
6%
Infection
8%
Ischemic Heart Disease
7%
Monotherapy
9%
N(g),n(g) Dimethylarginine
5%
Non ST Segment Elevation Myocardial Infarction
13%
Observational Study
14%
Pig
10%
Placebo
7%
Prasugrel
5%
Prevalence
6%
Randomized Clinical Trial
15%
Randomized Controlled Trial
6%
Rapamycin
9%
ST Segment Elevation Myocardial Infarction
58%
Stenosis
7%
Stent Thrombosis
24%
Symptom
10%
Takotsubo Cardiomyopathy
9%
Thorax Pain
7%
Thrombus
29%
Ticagrelor
5%
Troponin I
7%
Vaccination Policy
9%
Biochemistry, Genetics and Molecular Biology
All Cause Mortality
11%
Atrial Fibrillation
10%
Body Temperature
13%
Brown Bear
66%
Cardiac Troponin
9%
Heart Rate Variability
7%
Metabolic Pathway
6%
Observational Study
6%
Omega 3 Fatty Acid
5%
Pig
9%
ST Elevation
9%
Subadult
6%
Thrombocyte Function
7%
Troponin I
7%
